CONCENTRATION OF RISK (Details Narrative) - USD ($) |
9 Months Ended | |
|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Concentration Risk [Line Items] | ||
| Loan receivables | $ 2,200,000 | |
| Supplier Concentration Risk [Member] | Revenue Benchmark [Member] | Vendor [Member] | ||
| Concentration Risk [Line Items] | ||
| Concentration risk, percentage | 55.00% | 41.00% |
| Service [Member] | ||
| Concentration Risk [Line Items] | ||
| Payments to external professional service providers | $ 524,727 | $ 139,739 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|